A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
Public ClinicalTrials.gov record NCT05247489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Efficacy Study of Ruxolitinib Cream Combined With Narrow-Band Ultraviolet B Phototherapy in Participants With Vitiligo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).
Study identification
- NCT ID
- NCT05247489
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2022 (Actual)
- Primary completion
- Dec 19, 2023 (Actual)
- Completion
- Dec 19, 2023 (Actual)
- Last update posted
- Feb 20, 2025
2022 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| UC Davis Health | Sacramento | California | 95816 | — |
| Palo Alto Medical Foundation | Sunnyvale | California | 94086 | — |
| Delricht Clinical Research - Clinedge - Ppds Baton Rouge | Baton Rouge | Louisiana | 70809 | — |
| Aesthetic and Dermatology Center | Rockville | Maryland | 20850 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Metro Boston Clinical Partners | Brighton | Massachusetts | 02135 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01605 | — |
| Henry Ford Medical Center - New Center One | Detroit | Michigan | 48202 | — |
| Austin Institute For Clinical Research Aicr Pflugerville | Pflugerville | Texas | 78660 | — |
| Principle Research Solutions | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05247489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2025 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05247489 live on ClinicalTrials.gov.